About Omri Amirav-Drory
Form D filings for Talus Bioscience in 2024 list Omri Amirav-Drory as director.
Omri Amirav-Drory first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Omri Amirav-Drory in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Omri Amirav-Drory works with at each company, as listed on that company's latest Form D.
Talus Bioscience, Inc. · Form D, Aug 12, 2024
LP
Lindsay Pino
Executive officer and director
MB
Michelle Briscoe
Chief Operating Officer
AF
Alex Federation
Executive officer, director and promoter
JS
J. Strattan
Director